Screening for Colorectal Cancer: The Role of Clinical Laboratories.
Clin Chem
; 70(1): 150-164, 2024 01 04.
Article
en En
| MEDLINE
| ID: mdl-38175599
ABSTRACT
BACKGROUND:
Colorectal cancer (CRC) is a leading cause of cancer incidence and mortality. Screening can result in reductions in incidence and mortality, but there are many challenges to uptake and follow-up. CONTENT Here, we will review the changing epidemiology of CRC, including increasing trends for early and later onset CRC; evidence to support current and emerging screening strategies, including noninvasive stool and blood-based tests; key challenges to ensuring uptake and high-quality screening; and the critical role that clinical laboratories can have in supporting health system and public health efforts to reduce the burden of CRC on the population.SUMMARY:
Clinical laboratories have the opportunity to play a seminal role in optimizing early detection and prevention of CRC.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
2_ODS3
/
6_ODS3_enfermedades_notrasmisibles
Problema de salud:
2_muertes_prematuras_enfermedades_notrasmisibles
/
6_colon_rectum_cancers
Asunto principal:
Neoplasias Colorrectales
/
Servicios de Laboratorio Clínico
Tipo de estudio:
Diagnostic_studies
/
Screening_studies
Límite:
Humans
Idioma:
En
Revista:
Clin Chem
/
Clin. chem
/
Clinical chemistry
Asunto de la revista:
QUIMICA CLINICA
Año:
2024
Tipo del documento:
Article
País de afiliación:
Estados Unidos